Skip to main content
SpringerLink
Log in

Dapagliflozin, aflibercept, aripiprazole recommended by NICE

  • Guideline
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NICE. NICE says yes to dapagliflozin for some people with type 2 diabetes in final draft guidance. Media Release : 29 May 2013. Available from: URL: http://www.nice.org.uk.

  2. The National Institute for Health and Clinical Excellence (NICE). NICE gives green light to treatment for wet AMD in final draft guidance. Media Release : 30 May 2013. Available from: URL: http://www.nice.org.uk.

  3. NICE. NICE plans to recommend a new treatment for children with bipolar disorder. Media Release : 6 Jun 2013. Available from: URL: http://www.nice.org.uk.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dapagliflozin, aflibercept, aripiprazole recommended by NICE. PharmacoEcon Outcomes News 680, 14 (2013). https://doi.org/10.1007/s40274-013-0488-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0488-1

Search

Navigation